Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 2/20 | 0.55 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.55 |
| ▸ | LTA4H | P09960 | 1/20 | 0.49 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | ACE | P12821 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MME | P08473 | 1/20 | 0.46 |
| ▸ | CPA1 | P15085 | 1/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 2/20 | 0.44 |
| ▸ | MMP9 | P14780 | 2/20 | 0.44 |
| ▸ | MMP7 | P09237 | 1/20 | 0.44 |
| ▸ | MMP12 | P39900 | 1/20 | 0.44 |
| ▸ | MMP13 | P45452 | 1/20 | 0.44 |
| ▸ | MMP1 | P03956 | 1/20 | 0.43 |
| ▸ | MMP3 | P08254 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | NPY1R | P25929 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8938060 | 0.88 | ITGB3 (0.57) | ITGB3ITGA2BLTA4HLMNAALDH1A1 | |
| SCHEMBL829349 | 0.86 | SLC7A5 (0.51) | ITGB3ITGA2BLTA4H | |
| SCHEMBL7688895 | 0.85 | ITGB3 (0.57) | ITGB3ITGA2BFOLH1LMNAACE | |
| SCHEMBL7559199 | 0.83 | ITGB3 (0.52) | ITGB3ITGA2BLMNAALDH1A1MME | |
| SCHEMBL1406153 | 0.81 | CTSS (0.50) | — | |
| SCHEMBL8477239 | 0.81 | ITGB3 (0.62) | ITGB3ITGA2BFOLH1LMNAACE | |
| SCHEMBL9337698 | 0.81 | ITGB3 (0.62) | ITGB3ITGA2BFOLH1LMNAACE | |
| SCHEMBL11183676 | 0.81 | ITGB3 (0.62) | ITGB3ITGA2BFOLH1LMNAACE | |
| SCHEMBL8977599 | 0.80 | ITGB3 (0.56) | ITGB3ITGA2BFOLH1LMNAACE | |
| SCHEMBL16909929 | 0.80 | SLC7A5 (0.58) | ITGB3ITGA2BFOLH1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020137124-A1 | Process for the continuous production of dipeptide crystals in a membrane and hydro-cyclone reactor using a peptidase | INSTITUTO SUPERIOR TECHNICO (PT) | 2002-09-26 | — | — | US | disclosed |
| WO-2001088175-A1 | PROCESS FOR THE CONTINUOUS PRODUCTION OF DIPEPTIDE CRYSTALS IN A MEMBRANE AND HYDRO-CYCLONE REACTOR USING A PEPTIDASE | INSTITUTO SUPERIOR TÉCNICO (PT) | 2001-11-22 | — | — | WO | disclosed |
| US-5508182-A | PRODUCING AMPHIPHILIC COMPOUNDS, 1-MONOGLYCERIDES, SUGAR ETERS ON SOLID SUPPORTS USING A HYDROLASE | SCHNEIDER MANFRED P (DE) | 1996-04-16 | — | — | US | disclosed |
| WO-1992014830-A1 | ENZYMATIC REVERSE HYDROLYSIS OF HYDROPHILIC SUBSTRATES - PREPARATION OF AMPHIPHILIC COMPOUNDS | SCHNEIDER MANFRED P (DE) | 1992-09-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020137124-A1 | Process for the continuous production of dipeptide crystals in a membrane and hydro-cyclone reactor using a peptidase | LCT, PEPD, CPN1 | ITGB3 4862/4885ITGA2B 4867/4885LTA4H 297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.